Loading clinical trials...
Loading clinical trials...
VR for ICU Delirium Prevention
The purpose of this study is to evaluate whether daily exposure to immersive virtual reality (VR) can reduce the incidence of delirium in high-risk, non-intubated ICU patients. Participants will be randomized to either standard ICU care or standard care plus once-daily 15-minute VR sessions consisting of calming natural scenes, guided meditation, and music. The study population includes adult surgical ICU patients at Cedars-Sinai who are CAM-ICU negative at enrollment and possess at least one established risk factor for delirium. Outcomes will include the incidence and duration of delirium, ICU and hospital length of stay, feasibility of the VR intervention, and the frequency of adverse events. By targeting a high-risk population with an innovative non-pharmacologic therapy, this trial aims to generate data to support integration of VR into ICU delirium prevention protocols.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
Yes
Cedars Sinai Medical Center
Los Angeles, California, United States
Start Date
March 10, 2026
Primary Completion Date
January 15, 2028
Completion Date
April 1, 2028
Last Updated
March 17, 2026
822
ESTIMATED participants
Virtual Reality therapeutics
DEVICE
Lead Sponsor
Cedars-Sinai Medical Center
NCT06054828
NCT04876742
NCT06187792
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions